Projeto
New antitumor and antiangiogenic heterocyclic compounds: synthesis, molecular modeling, screening of enzymatic inhibition and studies in tumor and endothelial cell lines with tyrosine kinase membrane receptors as targets
| Referência: | PTDC/QUI-QUI/111060/2009 |
|---|---|
| Programa de financiamento: | 5876-PPCDTI |
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Instituto Politécnico de Bragança |
Registos relacionados
Synthesis of novel heterocyclic compounds based on rational design and evaluation of their antitumor and antiangiogenic potencial in human endothelial and tumor cell lines with tyrosine kinase membrane receptors as targets
New antitumor and/or anti-angiogenic heterocyclic compounds: Synthesis, molecular modelling and inhibition enzymatic assays using tyrosine kinase membrane growth factor receptors
Cell membrane features in HIV entry and its inhibition
Synthesis of new homooxacalixarene based anion receptors
Identify the mechanisms of endothelial tip cell invasive behavior in order to inhibit physiological and pathological sprouting angiogenesis
KINASE- Phosphoproteomics in Burkholderia to assess the role of tyrosine phosphorylation in virulence determinants expression
Adenosine receptors: new pharmacological targets for Rett syndrome treatment
Synthesis and Pre-clinical Evaluation of Novel Estradiol-Based Indium Complexes for Targeted Radiotherapy of Tumors
IMINOBORONATES AS USEFUL SCAFFOLDS FOR TUMOR-TARGETING
Design of iminoboronate based antitumor targeting conjugates
Targeting endothelial metabolism: a novel anti-angiogenic therapy
Ceramide and Glucosylceramide impact on membrane biophysical properties: from models of plasma- and lysosomal-membranes to the cell membrane
IN VIVO TARGETING OF PRO-TUMORAL CELL-INTRINSIC AND MICROENVIRONMENTAL SIGNALS IN T CELL ACUTE LYMPHOBLASTIC LEUKEMIA
“Polymer-metal based compounds to target nonhormone-responsive cancers: synthesis and mechanistic evaluation”
Design of novel breast tumor ‘targeted` multifunctional nanoparticles
Inhibition of bacterial plant virulence by interference with interspecies cell-cell communication.
FORCE TRANSMISSION AND ENDOTHELIAL CELL REARRANGEMENTS DURING VASCULAR REMODELING
Targeting cancer with ruthenium compounds
Targeting cancer with ruthenium compounds
Tumour-on-a-chip model to study the invasive potential of patient-derived Circulating Tumor Cells
Combinatorial Antibody Synthesis for the discovery of Targeted Immunomodulators
Sensing Cell-Cell Interaction Heterogeneity in 3D Tumor Models: Towards Precision Medicine (759959)
Targeting superficial tumors using a nanotechnological hybrid approach
Enzymatic synthesis of biodegradable amphiphilic polymer-drugs for cancer treatment (SFRH/BD/144303/2019)
THERAPEUTIC ACTIVITY OF A TARGETED DRUG DELIVERY APPROACH ON TUMOR METASTASIZATION
Epigenetic and metabolic regulation of endothelial heterogeneity
New insights into the regulation of insulin-sensitive glucose transporters by protein kinases
Synthesis and Study of New Organometallic Dendrimers for Nonlinear Applications
Unravelling and modulating the interplay between breast cancer cells and blood-brain barrier endothelial cells: a new hope to prevent brain metastasis formation
Adaptive and maladaptive endothelial cell dynamics during blood flow-driven vascular patterning
Simplified chip prototyping for improved screening of gene-silencing therapeutics using 3D cell models.
Novel Cel-based platform for drug screening targeting plasmodium hepatic infection
Tetraoxane-based tumor-activated prodrug strategy to target intracellular labile ferrous iron
NEW SYNTHETIC METHODOLOGY FOR THE ASYMMETRIC SYNTHESIS OF CARBOCYCLES
CHEMICAL LIBRARIES SCREENING - SEARCHING FOR NEW ANTI-MALARIAL DRUGS
SCREENING AND VALIDATION OF MOLECULES WITH THERAPEUTIC PROPERTIES IN IN VIVO MODELS OF PARKINSON’S DISEASE
The role of lipid membranes in Dengue virus cell infection
Microenvironmental effects on alternative splicing in malignant progression of colorectal tumor cells
Molecular basis of the contribution of a common AIRE allelic variant to the targeting of organ-specific autoimmunity and quality of anti-tumor responses
Development of a cell-based system for high-throughput screening of antifibrotics
Publicações relacionadas
Carregando publicações...